Sectra: Improved Cancer Care Through Interface between Sectra’s Digital Pathology Solution and Dutch LIMS Provider Finalist

Sectra AB (STO:SECTB)

International medical imaging IT company Sectra (http://www.sectra.com) (STO: SECT B) has announced that its digital pathology solution now has an interface with Finalist LIMS (Laboratory Information Management System). The interface facilitates a more efficient, completely paper-free pathology review workflow in which pathologists have access to both digital images and patient information from one single work location. This enables reduced lead times, thereby increasing efficiency in cancer care.

The interface between Sectra’s digital pathology solution and Finalist’s LIMS also improves the process of scanning glass slides. The appropriate scanning protocol is automatically selected, enabling high-volume scanning without any manual interference.

"This interface is key for the Dutch market and the latest example of our consistent strategy to improve reading and reporting efficiency in pathology through tight integration with surrounding IT systems, such as different LIMS systems,” says Simon Häger, Product Manager for Sectra’s pathology solution.

About Sectra’s digital pathology solution

Sectra provides a complete solution for primary diagnostics in pathology. The solution includes archiving and storage solutions together with high-end review workstations. It allows pathologists to make their diagnoses and reports with higher precision and less time spent per case. Sectra’s solution for digital pathology is built on the same platform as Sectra’s radiology PACS, the solution for managing radiology images. With a shared technical platform, images from both of the diagnostic specialties can be stored and displayed in a single system. This enables deeper cooperation between radiologists and pathologists and facilitates, for example, multidisciplinary rounds, which is a step in integrated diagnostics.

European and Scandinavian pathology departments are in the process of digitizing their work, but nonetheless, only a few hospitals have implemented full-scale digital pathology solutions. In the US, digital pathology for primary diagnostics is still pending FDA approval.

Further reading:

Read more about how care providers can benefit from Sectra’s integrated diagnostics solutions. (http://www.sectra.com/medical/press/pdf/Anna_leaflet_press_2.0.pdf)

About Sectra

The world needs more efficient healthcare and more secure communication. Sectra plays a key role in meeting these needs. Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 14 countries, and operates through partners worldwide. Sales in the 2014/2015 fiscal year totaled SEK 961 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit www.sectra.com

In the medical market, Sectra develops and sells IT solutions for the management and communication of all types of medical images – primarily in radiology, mammography, pathology and orthopaedics, as well as other departments where medical images are used. Sectra has a strategic focus on making cancer care more efficient. More than 1,700 hospitals, clinics and imaging centers worldwide use Sectra’s systems daily. This makes Sectra one of the world’s leading providers of IT solutions for managing medical images and patient information. The company commands a market-leading position in Sweden, Norway, the Netherlands and Portugal, holds a prominent position in the UK and is growing in the US. Sectra has delivered some of the largest installations of medical IT systems worldwide and its systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160310006727/en/